Navigation Links
Kessler Foundation scientists awarded New Jersey grants for brain injury research
Date:9/21/2012

WEST ORANGE, N.J.Two neuroscientists at Kessler Foundation received grants from the New Jersey Commission on Brain Injury Research. Helen Genova, Ph.D., research scientist in Neuropsychology & Neuroscience Research was awarded a three-year Individual Research Grant totaling $462,103. Starla Weaver, Ph.D., a postdoctoral fellow in Traumatic Brain Injury (TBI) Research, received a three-year Fellowship Research Grant for $199,764. Kessler Foundation conducts cognitive and mobility rehabilitation research in brain injury, spinal cord injury, stroke and multiple sclerosis.

Nancy Chiaravalloti, Ph.D., director of Traumatic Brain Injury and Neuropsychology & Neuroscience Research, commented, "We are pleased to have the support of the Commission for these important studies. Expanding our knowledge of how TBI affects brain function will help us to devise more effective strategies for cognitive rehabilitation."

Dr. Genova is interested in the long-term cognitive dysfunction that can cause disability after brain injury. While some recover over time, a significant number of individuals show continued impairment and even progressive cognitive decline. The identification of an accurate and reliable predictor of cognitive outcome would help to guide patients and families through the recovery process, but such a predictor has eluded investigators. Dr. Genova will apply a new neuroimaging technique, diffusion tensor imaging (DTI), to the study of the cognitive effects of TBI. DTI has proven to be a highly sensitive measure of diffuse axonal injury and white matter integrity, but few studies have applied DTI to the study of cognitive deficits in people more than two years post TBI. Delineating the relationship between diffuse axonal injury and cognitive impairment could transform the initial approach to rehabilitation and enable clinicians to provide patients and families with prognostic information regarding cognitive recovery. Dr. Genova's project is "The longitudinal examination of the relationship between white matter pathology & cognitive impairment in traumatic brain injury using diffusion tensor imaging."

Dr. Weaver's interest is in chronic cognitive deficits that are a major cause of disability after TBI. Her research focuses on executive function, which is the ability to organize thoughts and activities, prioritize tasks, manage time efficiently, and make decisions. Developing rehabilitation interventions that improve executive function will minimize disability and aid performance of daily activities necessary for independent living. Task switching, i.e., the ability to switch between two simple tasks, has been found to be the best predictor of performance of tasks related to executive function. Dr. Weaver will compare the effects of task-switching in individuals with TBI and controls to determine whether this type of intervention can provide lasting benefits. She will use functional MRI to compare patterns of cerebral activation with task switching in both groups. Dr. Weaver's project is "The effects of task switching training on traumatic brain injury."

Drs. Genova, Weaver and Chiaravalloti have faculty appointments in the department of physical medicine & rehabilitation at UMDNJ-New Jersey Medical School.


'/>"/>

Contact: Lauren Scrivo
lscrivo@kesslerfoundation.org
973-324-8384
Kessler Foundation
Source:Eurekalert

Related medicine news :

1. Kessler Foundation scientist garners best poster award for MS research
2. Dr. Chiaravalloti of Kessler Foundation comments on trends in rehabilitation research in MS
3. Kessler Foundation presents Brain Injury: From Research to Rebuilding Lives on Sept. 27-28
4. DeLuca of Kessler Foundation receives research award from American Psychological Association
5. Kessler Foundation and Heldrich Center issue brief on hiring workers with disabilities
6. Kessler Foundations A.M. Barrett appointed to National Quality Forum Steering Committee
7. Kessler Foundation scientists present cognitive research findings at MS dual symposium
8. Kessler Foundation researchers present at first International Congress on Cognition in MS
9. Kessler Foundation scientist awarded $554,000 for multiple sclerosis employment research
10. Kessler Foundation names Dr. John Whyte recipient of Foundations 2nd Annual DeLisa Award
11. Research prizes from the Carlsberg Foundation to researchers from University of Copenhagen
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/18/2017)... ... August 18, 2017 , ... ... LLC (“Quick”), a highly specialized asset-light logistics provider of complex transport solutions ... definitive agreement to purchase Unitrans International Corporation, a division of Roadrunner Transportation ...
(Date:8/18/2017)... ... August 18, 2017 , ... As an ... an educational webinar, they will present the line of epMotion automated liquid handling ... easy you can automate everyday pipetting tasks. , Ideal for scientists and lab ...
(Date:8/18/2017)... ... August 18, 2017 , ... Moore Insurance, a Houston ... east Texas, is launching a regional charity effort to provide publicity assistance and ... Pediatric Brain Tumor Foundation (PBTF) has raised nearly $30 million in donations that ...
(Date:8/18/2017)... ... August 18, 2017 , ... The Golseth Agency, a Texas based ... area, is spearheading a regional charity campaign organized to provide support to Christina Upchurch ... of this year, Christina and her children returned from out of town to find ...
(Date:8/18/2017)... ... August 18, 2017 , ... Alcovit, a lime-flavored beverage that rids the ... efforts with its product now available through Jet.com. , After 25 years of ... powdered drink is designed to quickly detox the body thereby avoiding alcohol-induced hangovers. Whether ...
Breaking Medicine News(10 mins):
(Date:8/15/2017)... 15, 2017 AccuGenomics, Inc., a diagnostic company ... announced that the company has provided an AccuKit to ... Carolina at Chapel Hill and to Qura Therapeutics for ... and quantify HIV reservoir and viral expression in human ... HIV Cure Center is a joint initiative between the ...
(Date:8/8/2017)... Israel, Aug. 8, 2017  BioLineRx Ltd. (NASDAQ/TASE: BLRX), ... today reports its financial results for the second quarter ... during the second quarter 2017 and to date: ... clinical development programs for the Company,s lead project, BL-8040: ... pivotal study with BL-8040 as novel stem cell mobilization ...
(Date:8/7/2017)... 2017  Diplomat Pharmacy, Inc. (NYSE: DPLO), the nation,s largest ... June 30, 2017.  All comparisons, unless otherwise noted, are to ... Second Quarter 2017 Highlights include: ... an increase of 3.5% Total prescriptions dispensed ... of 7.5% versus 7.6% Gross profit ...
Breaking Medicine Technology: